Gabriel Moya

Title: Gabriel Moya - Innovator in Virus Detection Technology

Introduction

Gabriel Moya is a notable inventor based in Munich, Germany. He has made significant contributions to the field of virus detection technology. His innovative work focuses on developing systems that enhance the rapid detection of intact viruses.

Latest Patents

Moya holds a patent for a "Flow virometer for rapid detection of intact viruses." This invention encompasses systems and methods that enable optical detection of nanoparticles based on size and their interaction with specific antibodies. The technology utilizes a biological sample combined with fluorescent dyes and fluorescently labeled antibodies. It allows for the detection of over 100 particles with diameters as small as 100 nm in under 10 minutes. The detection mechanisms integrate confocal detection of particles within microfluidic flow devices. By concentrating the sample through hydrodynamic focusing, the system can detect particles at concentrations as low as 10 particles per mL. This capability is crucial for identifying and quantifying viruses from bodily fluids, such as saliva, where relevant virus concentrations in potentially infected subjects range from 10 to 10 particles/mL. The flow virometer provides rapid, direct feedback regarding the presence of specific viruses in biological samples and serves as a foundation for future commercial products.

Career Highlights

Throughout his career, Gabriel Moya has worked with esteemed organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Ludwig-Maximilians-Universität. His work has significantly advanced the field of virology and diagnostics.

Collaborations

Moya has collaborated with notable individuals in his field, including Thorben Cordes and Yair Razvag. These partnerships have contributed to the development and refinement of his innovative technologies.

Conclusion

Gabriel Moya's contributions to virus detection technology exemplify the impact of innovation in healthcare. His patented flow virometer represents a significant advancement in the rapid detection of viruses, showcasing the potential for future commercial applications.